KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Zimmer Biomet Holdings (ZBH) over the last 17 years, with Q3 2025 value amounting to $55.0 million.

  • Zimmer Biomet Holdings' Capital Expenditures rose 2359.55% to $55.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $201.2 million, marking a year-over-year decrease of 646.21%. This contributed to the annual value of $203.8 million for FY2024, which is 2998.97% down from last year.
  • Zimmer Biomet Holdings' Capital Expenditures amounted to $55.0 million in Q3 2025, which was up 2359.55% from $50.1 million recorded in Q2 2025.
  • Zimmer Biomet Holdings' Capital Expenditures' 5-year high stood at $97.3 million during Q2 2023, with a 5-year trough of $24.6 million in Q2 2021.
  • Over the past 5 years, Zimmer Biomet Holdings' median Capital Expenditures value was $49.2 million (recorded in 2021), while the average stood at $51.4 million.
  • Per our database at Business Quant, Zimmer Biomet Holdings' Capital Expenditures skyrocketed by 13789.73% in 2023 and then crashed by 4721.23% in 2024.
  • Over the past 5 years, Zimmer Biomet Holdings' Capital Expenditures (Quarter) stood at $49.2 million in 2021, then rose by 28.86% to $63.4 million in 2022, then fell by 0.95% to $62.8 million in 2023, then dropped by 17.99% to $51.5 million in 2024, then increased by 6.8% to $55.0 million in 2025.
  • Its Capital Expenditures stands at $55.0 million for Q3 2025, versus $50.1 million for Q2 2025 and $44.6 million for Q1 2025.